Navigation Links
Study Showed Minimally Invasive Surgery Reduced Risk of Hospital-Acquired Infections Compared to Open Surgery
Date:4/10/2008

PHILADELPHIA, April 10 /PRNewswire/ -- SAGES 2008 ANNUAL MEETING - Ethicon Endo-Surgery today announced results from a new study showing laparoscopic surgery reduced the risk of nosocomial (hospital-acquired) infections by 52 percent when compared to open surgery in a sample of more than 11,000 patients undergoing one of the following three surgical procedures: hysterectomy, cholecystectomy (gallbladder removal) and appendectomy. Specific to individual surgeries, the study found laparoscopic surgery was associated with reduction of the risk of nosocomial infections during gallbladder removal by 66 percent, and during hysterectomy by 52 percent compared to open surgery. The study showed the reduction rates of nosocomial infections during laparoscopic appendectomy were not statistically significant.

The results of the study will be presented on April 12, 2008 at the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) Annual Meeting. The data also will be published in the April edition of Surgical Endoscopy, the official journal of SAGES.

The study, sponsored by Ethicon Endo-Surgery entitled "The Effects of Laparoscopic Cholecystectomy, Hysterectomy, and Appendectomy on Nosocomial Infection Risks," is the first to examine infections specific to these procedures 30 days post-discharge, providing a more comprehensive picture of infection patterns than previously available. The study discovered 40 percent of the infections identified occurred within 30 days after hospital discharge.

Results of the study also showed laparoscopic surgery was associated with a reduction in the overall odds ratio for each type of nosocomial infection. Compared to open surgery, patients in the study who underwent laparoscopic surgery experienced 80 percent reduction in the odds of respiratory tract infection, 69 percent reduction in bloodstream infection, 59 percent reduction in wound infection, 39 percent reduction in urinary tract infection and a
'/>"/>

SOURCE Ethicon Endo-Surgery
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. NEJM study demonstrates carotid stenting with embolic protection is comparable to surgery
2. Egg Consumption Poses Risks for Diabetic Men: Study
3. Haemacure Discloses Positive Results of a preclinical study of its fibrin sealant in adhesion prevention and opens a new opportunity in a market with a significant unmet medical need
4. Landmark Study Aims to Improve Osteoporosis Care Standards Worldwide
5. Forecasting MDs prescriptions choice? Ask their patients, says Management Insights study
6. Statement by the American Egg Board and Egg Nutrition Center on AJCN Study on Egg Consumption
7. Best Practices, LLC Announces New Benchmarking Study - How World-Class Companies Proactively Manage Competitors
8. Study: Health shocks diminish wealth more later in life
9. Study sheds light on link between sleep disorder, behavior issues in kids
10. Award-winning study says back pain may be in your genes
11. 2004 long-term care act raised costs and worsened care, study shows
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)...orporation Executive, Robert J. Reilly, Joins Aeth...on Inc.,( http://www.aethon.com ), the leading dev...n logistics, today announced that Robert J. Reilly...- Chief Financial Officer., Reilly, who was most ...esson Corporation,s Specialty Pharmacy Division, b...
(Date:7/25/2008)...25 /PRNewswire/ -- The Elekta Family of Companies ...t solutions at the 2008,American Association of Ph...trating how the joint forces of Elekta, IMPAC and ...planning and delivery solutions that,streamline th...for,patients, as well as enhance clinician efficie...
(Date:7/25/2008)...f., July 25 /PRNewswire/ -- AutoGenomics, Inc. tod...ement on Form S-1 with the,Securities and Exchange...c,offering of shares of its common stock. The numb... which are expected to be offered by,AutoGenomics,...not yet been,determined., J.P. Morgan Securities ...
(Date:7/25/2008)...ughest for those trying to drop pounds, study find...- Anyone who has avoided Monday morning weigh-ins ...ieter,s friend. , Now, researchers have some sc...s being their undoing: Most people do eat more on ...ht. , "Weekend indulgences can wreak havoc on w...
Breaking Medicine News(10 mins):Health News:Aethon, Inc. Names New Chief Financial Officer 2Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 2Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 3Health News:AutoGenomics, Inc. Files Registration Statement for Initial Public Offering 2Health News:Weekends Tough on the Diet 2Health News:Weekends Tough on the Diet 3
...r and death from cancer among Chinese women is ris...ai// Disease Prevention and Control Centre Friday....ghai urban area has almost doubled in 20 years and...ontracting the disease, the center reports. The l...
...rm Biocon Ltd Thursday announced the launch of ren...and reducing// the risk of such disease. As the l...ontinent, the company has set up a nephrology divi...odapt (Mycophenolate Mofeti), Tacrograf (Tacrolimu...
...a world-renowned California-based biomedical facil...ome up with a chemical// that would help prevent r...synthetic compound, called MTIP, blocks the action...-Releasing Factor (CRF), according to a joint anim...
...the food chain via the Bernard Matthews plant, whi...ird flu in early February this year. The Public ...ost 850 tons of turkey had to pass through the pla... had occurred in the interim period between outbre...
Other Medicine News:Health News:Biocon Unveils Renal Therapies for Kidney Disorders 2
(Date:7/24/2008)...re/ -- There are a record 301,new medicines being ...,report released here today during a briefing that...lnesses have on patients, their families,and soci...million American,adults. The briefing, led by the ...ca (PhRMA), featured Emmy Award-winning actor Joey...
(Date:7/24/2008)...-- MacroChem Corporation (OTC,Bulletin Board: MACM...ial,involving 37 patients who completed a 48-week,... study of EcoNail, a topical antifungal,lacquer fo...e composite,primary efficacy endpoint of the trial...(negative fungal culture and negative KOH) and cle...
(Date:7/23/2008)...armaceuticals (SPI) has filed,an Investigational N...testing of a proprietary formulation of ebselen fo...oss or ototoxicity. The oral capsule,containing eb...lung cancer,and head and neck cancer patients rece...second development program for SPI to enter clinic...
(Date:7/23/2008)...Code BioPharmaceutics, Inc.,an emerging biopharma...,results demonstrating the utility of their lead d...chronic blood disorder paroxysmal nocturnal,hemogl...nted at the XXII,International Complement Workshop...only treatment currently available for PNH patient...
Breaking Medicine Technology:More Than 300 New Medicines Being Developed for Mental Illnesses 2More Than 300 New Medicines Being Developed for Mental Illnesses 3More Than 300 New Medicines Being Developed for Mental Illnesses 4MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 2MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 3MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 4MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 5Sound Pharmaceuticals Files Second IND with the FDA for the Prevention of Chemotherapy Induced Hearing Loss in Advanced Stage Cancer 2InCode BioPharmaceutics, Inc. Announces Key Data Supporting New Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) 2MIT works toward novel therapeutic device 4265 1MIT works toward novel therapeutic device 4265 2MIT works toward novel therapeutic device 4265 3Endobronchial valve significantly improves emphysema 912 1Endobronchial valve significantly improves emphysema 912 2Kidney Care Community Voices Strong Support for Kidney Patients Right to Choose 4261 1Kidney Care Community Voices Strong Support for Kidney Patients Right to Choose 4261 2Kidney Care Community Voices Strong Support for Kidney Patients Right to Choose 4261 3New Study Shows Lower Costs Increased Consumer Engagement in Account Based Health Plans 4257 1New Study Shows Lower Costs Increased Consumer Engagement in Account Based Health Plans 4257 2
...NESS WIRE)--Jun 19, 2007 - Geron,Corporation (Nasd...,the scalable production, survival following engra...infarcted rats was presented,today for GRNCM1, the...therapeutic for heart failure, at the Internationa...eting in Cairns,Australia., The presentation was ...
...SS WIRE)--Jun 19, 2007 - Javelin,Pharmaceuticals (...ate Rylomine(TM) (intranasal morphine) successfull...e Pain Intensity Difference,(SPID) scores over 0-2...tal Phase 3 studies, patients with moderate-to-sev...ven 7.5 mg Rylomine every,hour as needed, 15 mg Ry...
Other Medicine Technology:Research Documents Scalable Production, Survival Following,Engraftment and Positive Impact on Cardiac Function in Infarcted,Rats for Geron's Human Embryonic Stem Cell-Based Therapeutic for,Heart Failure 2Research Documents Scalable Production, Survival Following,Engraftment and Positive Impact on Cardiac Function in Infarcted,Rats for Geron's Human Embryonic Stem Cell-Based Therapeutic for,Heart Failure 3Research Documents Scalable Production, Survival Following,Engraftment and Positive Impact on Cardiac Function in Infarcted,Rats for Geron's Human Embryonic Stem Cell-Based Therapeutic for,Heart Failure 4Research Documents Scalable Production, Survival Following,Engraftment and Positive Impact on Cardiac Function in Infarcted,Rats for Geron's Human Embryonic Stem Cell-Based Therapeutic for,Heart Failure 5Research Documents Scalable Production, Survival Following,Engraftment and Positive Impact on Cardiac Function in Infarcted,Rats for Geron's Human Embryonic Stem Cell-Based Therapeutic for,Heart Failure 6Javelin Pharmaceuticals Announces Successful Pivotal Phase 3 Trial,Data 2Javelin Pharmaceuticals Announces Successful Pivotal Phase 3 Trial,Data 3Javelin Pharmaceuticals Announces Successful Pivotal Phase 3 Trial,Data 4
... OPMI Vario/NC33 System, Carl Zeiss has successful...et. , ,The success of this instrument is by n...ct and stylish design. Maximum ergonomic convenien...n to be used with a surgical microscope, allowing ...
...g; Suction Punch Forceps provide superior tissue e.... Shutt® Suction Graspers offer an aggressive ...he jaws. Both feature a unique stress pin bufferin...In use, the stress pin buffering system applies in...
Leg holder for arthroscopy.
Osteoprep instruments provide an array of bone shaping devices especially suited for notchplasties.
Medicine Products: